References
- Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, . Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–23.
- Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, . A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–31.
- Violini R, Musto C, De FF, Nazzaro MS, Cifarelli A, Petitti T, . Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial. J Am Coll Cardiol. 2010;55:810–4.
- Di LE, Sauro R, Varricchio A, Carbone G, Cortese G, Capasso M, . Long-term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: Results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty (PASEO) randomized trial. Circulation 2009;120:964–72.
- Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009;360:1946–59.
- Bocksch W, Pomar F, Dziarmaga M, Tresukosol D, Ismail O, Janek B, . Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: Results of the real world coroflex blue registry. Catheter Cardiovasc Interv 2010;75:78–85.
- Kereiakes DJ, Cox DA, Hermiller JB, Midei MG, Bachinsky WB, Nukta ED, . Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol. 2003;92:463–6.
- Kastrati A, Hall D, Schomig A long-term outcome after coronary stenting. Curr Control Trials Cardiovasc Med. 2000;1:48–54.
- Schofer J, Schluter M. Are drug-eluting stents a panacea for patients with coronary heart disease? Lancet 2004;364:558–9.
- Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Munzel T, . Randomized, double-blind, multicenter study of the endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006;114:798–806.
- Serruys PW, Ong AT, Piek JJ, Neumann FJ, van der Giessen WJ, Wiemer M, . A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention 2005;1:58–65.
- Visconti G, Focaccio A, Tavano D, Airoldi F, Briguori C. The CID Chrono cobalt-chromium alloy carbofilm-coated coronary stent system. Int J Cardiol. 2010;149(2):199–204.
- Sketch MH, Jr, Ball M, Rutherford B, Popma JJ, Russell C, Kereiakes DJ. Evaluation of the medtronic (driver) cobalt-chromium alloy coronary stent system. Am J Cardiol 2005;95:8–12.